<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Degiannis, D.</style></author><author><style face="normal" font="default" size="100%">Kalteziotis,V.</style></author><author><style face="normal" font="default" size="100%">Thalassinos,A.</style></author><author><style face="normal" font="default" size="100%">Kapsalis,A.</style></author><author><style face="normal" font="default" size="100%">Kroupis, C.</style></author><author><style face="normal" font="default" size="100%">Koniavitou,K.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes</style></title><secondary-title><style face="normal" font="default" size="100%">Transplant.Proc.</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cells,Cultured</style></keyword><keyword><style  face="normal" font="default" size="100%">Cyclosporine</style></keyword><keyword><style  face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style  face="normal" font="default" size="100%">Greece</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">immunology</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunosuppressive Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Interleukin-15</style></keyword><keyword><style  face="normal" font="default" size="100%">Interleukin-2</style></keyword><keyword><style  face="normal" font="default" size="100%">Kinetics</style></keyword><keyword><style  face="normal" font="default" size="100%">Lymphocyte Activation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lymphocytes</style></keyword><keyword><style  face="normal" font="default" size="100%">Muromonab-CD3</style></keyword><keyword><style  face="normal" font="default" size="100%">pharmacology</style></keyword><keyword><style  face="normal" font="default" size="100%">Polyenes</style></keyword><keyword><style  face="normal" font="default" size="100%">Recombinant Proteins</style></keyword><keyword><style  face="normal" font="default" size="100%">Sirolimus</style></keyword><keyword><style  face="normal" font="default" size="100%">Time Factors</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">1998</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1998/06//</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">PM:9636382</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">30</style></volume><pages><style face="normal" font="default" size="100%">948 - 949</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">4</style></issue><notes><style face="normal" font="default" size="100%">DA - 19980708IS - 0041-1345 (Print)IS - 0041-1345 (Linking)LA - engPT - Journal ArticleRN - 0 (Immunosuppressive Agents)RN - 0 (Interleukin-15)RN - 0 (Interleukin-2)RN - 0 (Muromonab-CD3)RN - 0 (Polyenes)RN - 0 (Recombinant Proteins)RN - 83HN0GTJ6D (Cyclosporine)RN - W36ZG6FT64 (Sirolimus)SB - IM</style></notes></record></records></xml>